Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial
British Journal of Cancer, Published online: 12 March 2024; doi:10.1038/s41416-024-02652-4Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Jinlin Cai Kaixin Lin Tongfeng Luo Jingrong Weng Haotian Liu Ze Yuan Zixiao Wan Junyi Han Jinxin Lin Xiaoxia Liu Xiaolin Wang Meijin Huang Yanxin Luo Huichuan Yu Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers | UK Health